GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the SARS-cov-2 (COVID-19) main protease in complex with UAW243

Analyse Crystal structure of the SARS-cov-2 (COVID-19) main protease in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6XFN
Type
protein
Length
305 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase; UAW243
EC
3.4.22.69
UniProt
P0DTD1
Ligands
UZ7, V1V, APY
Pockets
3 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30426% helix, 29% strandP0DTD1
BUAW243protein10% helix, 0% strand—

Ligands and binding sites

  • UZ7 · Phenyl hydrogen carbonate · ligand · chains A, B
  • V1V · (2S,3S)-3-amino-2-hydroxyhexanoic acid · ligand · chains A, B
  • APY · 2-aminomethyl-pyridine · ligand · chains A, B
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11910.620.8327V1V, APY
2790.330.7514empty
3500.300.7616empty

Interfaces

1 interface between chains.

  • A–B · 115 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 3 covalent (covalent ligand).

Compared structures

  • 6XFN · Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW243 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.